StockData
INSMED Inc logo

INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3096% above fair value
$144.46+24.66 (+20.58%)

Close on Nov 19, 2026Market cap $31.69BP/E –Yield –

Insmed shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Insmed's shares outstanding was 219M at Sep 30, 2026. For fiscal 2025 it was 199M, up 21.3% from the year before. Over ten years it grew 13.0% a year on average. The highest annual figure on record is 199M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 2025199M+21.3%
FY2024Dec 31, 2024164M+16.8%
FY2023Dec 31, 2023140M+14.1%
FY2022Dec 31, 2022123M+9.7%
FY2021Dec 31, 2021112M+14.9%
FY2020Dec 31, 202098M+15.4%
FY2019Dec 31, 201985M+10.0%
FY2018Dec 31, 201877M+15.5%
FY2017Dec 31, 201767M+7.6%
FY2016Dec 31, 201662M+5.6%
FY2015Dec 31, 201559M+36.1%
FY2014Dec 31, 201443M+23.2%
FY2013Dec 31, 201335M+31.8%
FY2012Dec 31, 201227M+13.7%
FY2011Dec 31, 201123M+76.2%
FY2010Dec 31, 201013M+104009.4%
FY2009Dec 31, 20090M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026219M+3.3%
Q2 FY2026Jun 30, 2026217M+14.8%
Q1 FY2026Mar 31, 2026215M+19.1%
Q4 FY2025Dec 31, 2025214M+19.3%
Q3 FY2025Sep 30, 2025212M+21.9%
Q2 FY2025Jun 30, 2025189M+22.4%
Q1 FY2025Mar 31, 2025181M+21.8%
Q4 FY2024Dec 31, 2024179M+23.7%
Q3 FY2024Sep 30, 2024174M+21.6%
Q2 FY2024Jun 30, 2024155M+12.5%
Q1 FY2024Mar 31, 2024148M+8.9%
Q4 FY2023Dec 31, 2023145M+9.1%
Q3 FY2023Sep 30, 2023143M+18.3%
Q2 FY2023Jun 30, 2023138M+15.0%
Q1 FY2023Mar 31, 2023136M+14.7%
Q4 FY2022Dec 31, 2022133M+12.0%
Q3 FY2022Sep 30, 2022121M+3.2%
Q2 FY2022Jun 30, 2022120M+9.1%
Q1 FY2022Mar 31, 2022119M+15.4%
Q4 FY2021Dec 31, 2021119M+15.9%
Q3 FY2021Sep 30, 2021117M+15.2%
Q2 FY2021Jun 30, 2021110M+13.4%
Q1 FY2021Mar 31, 2021103M+14.8%
Q4 FY2020Dec 31, 2020102M+14.3%
Q3 FY2020Sep 30, 2020102M+13.9%
Q2 FY2020Jun 30, 202097M+18.1%
Q1 FY2020Mar 31, 202090M+15.8%
Q4 FY2019Dec 31, 201990M+16.1%
Q3 FY2019Sep 30, 201989M+15.8%
Q2 FY2019Jun 30, 201982M+6.6%
Q1 FY2019Mar 31, 201978M+1.2%
Q4 FY2018Dec 31, 201877M+0.5%
Q3 FY2018Sep 30, 201877M+18.0%
Q2 FY2018Jun 30, 201877M+23.4%
Q1 FY2018Mar 31, 201877M+23.5%
Q4 FY2017Dec 31, 201777M+23.8%
Q3 FY2017Sep 30, 201765M–
Q2 FY2017Jun 30, 201762M–
Q1 FY2017Mar 31, 201762M–
Q4 FY2016Dec 31, 201662M–

More Insmed figures

See a number that looks wrong?